Alupent (Metaproterenol Sulfate Inhalation) - Side Effects and Adverse Reactions

ADVERSE REACTIONS

Adverse reactions are similar to those noted with other sympathomimetic agents. The most frequent adverse reaction to Alupent^® (metaproterenol sulfate USP) administered by metered-dose inhaler among 251 patients in 90-day controlled clinical trials was nervousness. This was reported in 6.8% of patients. Less frequent adverse experiences, occurring in 1-4% of patients were headache, dizziness, palpitations, gastrointestinal distress, tremor, throat irritation, nausea, vomiting, cough and asthma exacerbation. Tachycardia occurred in less than 1% of patients.

REPORTS OF SIDE EFFECTS / ADVERSE REACTIONS RELATED TO ALUPENT

Possible Alupent side effects / adverse reactions in 80 year old male

Reported by a health professional (non-physician/pharmacist) on 2009-12-29

Patient: 80 year old male

Reactions: Chest Pain, Atrial Fibrillation, Hyperhidrosis, Acute Myocardial Infarction

Adverse event resulted in: hospitalization

Suspect drug(s):
Alupent

Other drugs received by patient: Amoxicillin; Aspirin; Bisoprolol; CO-Codamol; Gaviscon; Lactulose; Senna

Possible Alupent side effects / adverse reactions in 83 year old female

Reported by a individual with unspecified qualification on 2010-01-12

Patient: 83 year old female weighing 56.0 kg (123.2 pounds)

Reactions: Atrial Fibrillation, Sinus Arrest

Suspect drug(s):
Isoproterenol HCL
    Dosage: 0.01 y
    Indication: Torsade DE Pointes

Alupent
    Dosage: 30 mg
    Administration route: Oral
    Indication: Torsade DE Pointes

Other drugs received by patient: Magnesium Sulfate; Lidocaine; Potassium Chloride; Cilostazol; Spironolactone; Olmesartan; Temocapril

Possible Alupent side effects / adverse reactions in 48 year old male

Reported by a individual with unspecified qualification from United States on 2010-03-08

Patient: 48 year old male weighing 88.5 kg (194.6 pounds)

Reactions: Product Quality Issue, Drug Effect Decreased, Exercise Tolerance Decreased

Suspect drug(s):
Alupent